Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: Investigation of the right and left hippocampus, thalamus, and prefrontal cortex

Schizophrenia Bulletin

Volumn 28, Issue 2, 2002, Pages 329-339

  Delamillieure, Pascal ^a   Constans, Jean Marc ^a   Fernandez, Jésus ^a   Brazo, Périne ^a   Benali, Karim ^a   Courthéoux, Patrick ^a   Thibaut, Florence ^b   Petit, Michel ^b   Dollfus, Sonia ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

Brain chemistry; Hippocampus; Magnetic resonance spectroscopy; Prefrontal cortex; Schizophrenia; Thalamus

Indexed keywords

AMISULPRIDE; CREATINE; CREATINE PHOSPHATE; FLUPENTIXOL; HALOPERIDOL; INOSITOL; LOXAPINE; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; PENFLURIDOL; PIMOZIDE; PIPOTIAZINE; PROTON;

ADULT; AMPLITUDE MODULATION; ARTICLE; BRAIN ASYMMETRY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; HIPPOCAMPUS; HUMAN; MALE; NERVE DEGENERATION; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; THALAMUS; HEMISPHERIC DOMINANCE; HOSPITALIZATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYSIOLOGY; QUESTIONNAIRE;

ADULT; FEMALE; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; PROTONS; QUESTIONNAIRES; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; THALAMUS;

EID: 0036456277     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a006942     Document Type: Article

References (57)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. 4th Ed. Washington, DC: APA, 1994.
2. Andreasen, N.C.; Arndt, S.; Swayze, V.W., 2nd; Cizadlo, T.; Flaum, M.; O'Leary, D.; Ehrhardt, J.C.; and Yuh, W.T.C. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science, 266:294-298, 1994.
3. Andreasen, N.C.; Olsen, S.A.; Dennert, J.W.; and Smith, M.R. Ventricular enlargement in schizophrenia: Relationship to positive and negative symptoms. American Journal of Psychiatry, 139:297-302, 1982.
4. Arnold, D.L.; Matthews, P.M.; Francis, G.S.; O'Connor, J.; and Antel, J.P. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Annals of Neurology, 31:235-241, 1992.
5. Bartha, R.; Al-Semaan, Y.M.; Williamson, P.C.; Drost, D.J.; Malla, A.K.; and Carr, T.J. A short echo proton magnetic resonance spectroscopy study of the left medial temporal lobe in first-onset schizophrenia patients. Biological Psychiatry, 45:1403-1411, 1999.
6. Bertolino, A.; Callicott, J.H.; Elman, I.; Mattay, V.S.; Tedeschi, G.; Frank, J.A.; Breier, A.; and Weinberger, D.R. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic imaging study. Biological Psychiatry, 43:641-648, 1998.
7. Bertolino, A.; Nawroz, S.; Mattay, V.S.; Barnett, A.S.; Duyn, J.H.; Moonen, C.T.W.; Frank, J.A.; Tedeschi, G.; and Weinberger, D.R. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. American Journal of Psychiatry, 153:1554-1563, 1996.
8. Bilder, R.M.; Wu, H.; Bogerts, B.; Degreef, G.; Ashtari, M.; Alvir, J.M.J.; Snyder, P.J.; and Lieberman, J.A. Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. American Journal of Psychiatry, 151:1437-1447, 1994.
9. Birken, D.L., and Oldendorf, W.H. N-acetyl-L-aspartic acid: A literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neuroscience and Biobehavioral Reviews, 13:23-31, 1989.
10. Bogerts, B.; Meertz, E.; and Schönfeldt-Bausch, R. Basal ganglia and limbic system pathology in schizophrenia: A morphometric study of brain volume and shrinkage. Archives of General Psychiatry, 42:784-791, 1985.
11. Brand, A.; Richter-Landsberg, C.; and Leibfritz, D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Development in Neuroscience, 15:289-298, 1993.
12. Breier, A.; Buchanan, R.W.; Elkashef, A.; Munson, R.C.; Kirkpatrick, B.; and Cellad, F. Brain morphology and schizophrenia: A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archives of General Psychiatry, 49:921-926, 1992.
13. Buckley, P.F.; Moore, C.; Long, H.; Larkin, C.; Thompson, P.; Mulvany, F.; Redmond, O.; Stack, J.P.; Ennis, J.T.; and Waddington, J.L. 1H magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates. Biological Psychiatry, 36:792-800, 1994.
14. 31Phosphorus magnetic resonance spectroscopy of the temporal lobes in schizophrenia. Biological Psychiatry, 32:26-32, 1992.
15. Casanova, M.F. Astrocytosis and schizophrenia. Schizophrenia Research, 5:186-187, 1991.
16. Cecil, K.M.; Lenkenski, R.E.; Gur, R.E.; and Gur, R.C. Proton magnetic resonance spectroscopy in the frontal and temporal lobes of neuroleptic-naive patients with schizophrenia. Neuropsychopharmacology, 20:131-140, 1999.
17. Charles, H.C.; Lazeyras, F.; Krishnan, K.R.; Boyko, O.B.; Patterson, L.J.; Doraiswamy, P.M.; and McDonald, W.M. Proton spectroscopy of human brain: Effects of age and sex. Progress in Neuropsychopharmacology and Biological Psychiatry, 18(6):995-1004, 1994.
18. Davis, J.M. Comparative doses and costs of antipsychotic medication. Archives of General Psychiatry, 33:858-861, 1976.
19. Davis, K.L.; Buchsbaum, M.S.; Shihabuddin, L.; Spiegel-Cohen, J.; Metzger, M.; Frecska, E.; Keefe, R.S.; and Powchik, P. Ventricular enlargement in pooroutcome schizophrenia. Biological Psychiatry, 43:783-793, 1998.
20. Deicken, R.F; Zhou, L.; Corwin, F.; Vinagradov, S.; and Weiner, M.W. Decreased left frontal lobe N-acetylaspartate in schizophrenia. American Journal of Psychiatry, 154:688-690, 1997.
21. DeLisi, L.E. The significance of age of onset for schizophrenia. Schizophrenia Bulletin, 18(2):209-215, 1992.
22. DeLisi, L.E.; Gupta, S.M.; Hoff, A.; Shields, A.; Schwartz, J.; Halthore, S.; and Anand, A. A brain morphology in first episode cases of schizophrenia. Schizophrenia Research, 3:20, 1990.
23. DeLisi, L.E.; Sakuma, M.; Kushner, M.; Finer, D.L.; Hoff, A.L.; and Crow, T.J. Anomalous cerebral asymmetry and language processing in schizophrenia. Schizophrenia Bulletin, 23(2):255-271, 1997a.
24. DeLisi, L.E.; Sakuma, M.; Tew, W.; Kushner, M.; Hoff, A.L.; and Grimson, R. Schizophrenia as a chronic active brain process: A study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Research, 74:129-140, 1997b.
25. DeStephano, N.; Matthews, P.M.; Antel, J.P.; Preul, M.; Francis, G.; and Arnold, D.L. Chemical pathology of acute demyelinating lesions and its correlation with disability. Annals of Neurology, 38:901-909, 1995.
26. Ende, G.; Braus, D.F.; Walter, S.; Weber-Fahr, W.; Soher, B.; Maudsley, A.A.; and Henn, F.A. Effects of age, medication and illness duration on the N-acetyl-aspartate signal of the anterior cingulated region in schizophrenia. Schizophrenia Research, 41:389-395, 2000.
27. Frahm, J.; Bruhn, H.; Gyngell, M.L.; Merboldt, K.D.; Hänicke, W.; and Sauter, R. Localized high resolution proton NMR spectroscopy using stimulated echos: Initial application to human brain in vivo. Magnetic Resonance in Medicine, 9:73-93, 1989a.
28. Frahm, J.; Bruhn, H.; Gyngell, M.L.; Merboldt, K.D.; Hänicke, W.; and Sauter, R. Localized proton NMR spectroscopy in different regions of the human brain in vivo: Relaxation times and concentrations of cerebral metabolites. Magnetic Resonance in Medicine, 11:47-63, 1989b.
29. Fukuzako, H.; Fukuzako, T.; Hashiguchi, T.; Hokazono, Y.; Takeuchi, K.; Hirakawa, K.; Ueyama, K.; Takigawa, M.; Kajima, Y.; Nakajo, M.; and Fujimoto, T. Reduction in hippocampal formation volume is caused mainly by its shortening in chronic schizophrenia: Assessment by MRI. Biological Psychiatry, 39:938-945, 1996.
30. Fukuzako, H.; Takeuchi, K.; Hokazono, Y.; Fukuzako, T.; Yamada, K.; Hashiguchi, T.; Obo, Y.; Ueyama, K.; Takigawa, M.; and Fujimoto, T. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: Preliminary report. Psychiatry Research, 61:193-200, 1995.
31. Golden, C.J.; Graber, B.; Coffman, J.; Berg, R.A.; Newlin, D.B.; and Block, S. Structural brain deficits in schizophrenia: Identification by computed tomographic scan density measurements. Archives of General Psychiatry, 38:1014-1017, 1981.
32. Gur, R.C.; Packer, I.K.; Hungerbuhler, J.P.; Reivich, M.; Obrist, W.D.; Amarneck, W.S.; and Sackheim, H.A. Differences in the distribution of gray and white matter in human cerebral hemispheres. Science, 207:1226-1228, 1980.
33. Heimberg, C.; Komoroski, R.A.; Lawson, W.B.; Cardwell, D.; and Karson, C.N. Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect. Psychiatry Research, 83:105-115, 1998.
34. Kay, S.R.; Fiszbein, A.; and Opler, L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13(2):261-276, 1987.
35. Kertesz, A.; Polk, M.; and Black, S.E.J.H. Sex, handedness, and the morphometry of cerebral asymmetries on magnetic resonance imaging. Brain Research, 530:40-48, 1990.
36. LeMay, M. Morphological cerebral asymmetries of modem man, fossil man, and non-human primate. Annals of NY Academy of Sciences, 280:349-356, 1976.
37. Lim, K.O.; Adalsteinsson, E.; Spielman, D.; Sullivan, E.V.; and Rosenbloom, M.J. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Archives of General Psychiatry, 55:346-352, 1998.
38. Luchins, D.J.; Weinberger, D.R.; and Wyatt, R.J. Schizophrenia: Evidence of a subgroup with reversal cerebral asymmetry. American Journal of Psychiatry, 36:1309-1311, 1979.
39. Maier, M. In vivo magnetic resonance spectroscopy: Applications in psychiatry. British Journal of Psychiatry, 167:299-306, 1995.
40. Marsh, L.; Suddath, R.L.; Higgins, N.; and Weinberger, D.R. Medial temporal lobe structures in schizophrenia: Relationship of size to duration of illness. Schizophrenia Research, 11:225-238, 1994.
41. Miller, B.L.; Moats, R.; Shonk, T.; Ernst, T.; Wooley, S.; and Ross, B.D. Alzheimer's disease: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology, 187:433-437, 1993.
42. Murray, R.M.; O'Callaghan, E.; Castle, D.J.; and Lewis, S.W. A neurodevelopmental approach to the classification of schizophrenia. Schizophrenia Bulletin, 18(2):319-332, 1992.
43. Nasrallah, H.A.; Olson, S.C.; McCalley-Whitters, M.; Chapman, S.; and Jacoby, C.G. Cerebral ventricular enlargement in schizophrenia. Archives of General Psychiatry, 43:157-159, 1986.
44. Oldfield, R.C. The assessment and analysis of handedness: The Edinburgh inventory. Neuropsychologia, 9:97-113, 1971.
45. Petty, R.G. Structural asymmetries of the human brain and their disturbance in schizophrenia. Schizophrenia Bulletin, 25(1):121-139, 1999.
46. Renshaw, P.F.; Yurgelun-Todd, D.A.; Tohen, M.; Gruber, S.A.; and Cohen, B.M. Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. American Journal of Psychiatry, 152:444-446, 1995.
47. Robins, L.N.; Helzer, J.E.; Groughan, J.; and Ratcliff, K.S. National Institute of Mental Health Diagnostic Interview Schedule: Its history, characteristics and validity. Archives of General Psychiatry, 38:381-389, 1981.
48. Rossi, G.F.; Stratta, P.; D'Albenzio, L.; Tartaro, A.; Schiazza, G.; Di Michele, V.; Bolino, F.; and Casacchia, M. Reduced temporal lobe areas in schizophrenia: Preliminary evidence from a controlled multiplanar magnetic resonance study. [Abstract]. Schizophrenia Research, 3:21, 1990.
49. Shioiri, T.; Hamakawa, H.; Kato, T.; Murashita, J.; Fujii, K.; Inubushi, T.; and Takahashi, S. Proton magnetic resonance spectroscopy of the basal ganglia in patients with schizophrenia: A preliminary report. Schizophrenia Research, 22:19-26, 1996.
50. Silbersweig, D.A.; Stern, E.; Frith, C.; Cahill, C.; Holmes, A.; Grootoonk, S.; Seaward, J.; McKenna, P.; Chua, S.E.; Schnorr, L.; Jones, T.; and Frackowiak, R.S.J. A functional neuroanatomy of hallucinations in schizophrenia. Nature, 378:176-179, 1995.
51. Stevens, J.R. Neuropathology of schizophrenia. Archives of General Psychiatry, 39:1131-1139, 1982.
52. Tedeschi, G.; Bertolino, A.; Righini, A.; Campbell, G.; Raman, R.; Duyn, J.H.; Moonen, C.T.W.; Alger, J.R.; and DiChiro, G. Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology, 45:1384-1391, 1995.
53. Urenjak, J.; Williams, S.R.; Gadian, D.G.; and Noble, M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. Journal of Neuroscience, 13:981-989, 1993.
54. Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44:660-669, 1987.
55. Weinberger, D.R.; Luchins, D.J.; Morihisa, J.; and Wyatt R.J. Asymmetrical volumes of the right and left frontal and occipital regions of the human brain. Annals of Neurology, 11:97-100, 1982.
56. Williamson, P.C.; Bartha, R.; Drost, D.J.; Malla, A.; Carr, T.; Canaran, G.; Densmore, M.; and Neufeld, R.W.J. Medial prefrontal 1H MRS and MRI findings in nevertreated schizophrenics and healthy controls. [Abstract]. Schizophrenia Research, 29:101, 1998.
57. Yurgelun-Todd, D.A.; Renshaw, P.F.; Gruber, S.A.; Watemaux, C.M.; and Cohen, B.M. Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophrenia Research, 19:55-59, 1996.